Delivery Order SPE2DB24D3015-SPE2DB25FGBBV
- Not listed
- The Defense Logistics Agency awarded a $14,765.41 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical products. This is a firm fixed price, non-set-aside contract with a completion date of August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,398.85 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $17,422.25 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in treating inflammatory conditions. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 4, 2025, and performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,741.71 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical supplies. The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,510.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL pharmaceutical supplies on September 3, 2025, with completion targeted for September 4, 2025. This non-competitive delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $8,170 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on April 21, 2025, with an ultimate completion date of April 22, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical product will be performed at the contractor's Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, for $6,797.70 to supply HUMIRA (CF) Pen 40 mg/0.4 mL units. This non-competitive delivery order was issued under a firm fixed price structure with a completion date of July 31, 2025, and represents a single transaction on the company's broader pharmaceutical supply contract with DLA. The place of performance is located at the...
- The Defense Logistics Agency awarded a $4,736.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL pharmaceutical supplies, with an ultimate completion date of September 4, 2025. This non-set-aside competitive award was executed on September 3, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $7,810.81 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. The contract, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will take...
- The Defense Logistics Agency awarded a delivery order valued at $2,265.90 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGBBVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,586.76 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle supplying military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, demonstrates significant capability in federal medical procurement through its extensive portfolio of pharmaceutical products and medical supplies. The company's federal contract awards with the Defense Logistics Agency and its Medical Supply Chain reflect competitively awarded arrangements covering a wide spectrum of pharmaceuticals, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The prime IDC vehicle enables the company to serve critical customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning AmerisourceBergen Drug Corp as a key vendor supporting military and veteran healthcare supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 9/23/25 |